Seeking Alpha

An FDA panel recommends expanding the use of Roche's (RHHBY.PK) Lucentis for treating diabetic...

An FDA panel recommends expanding the use of Roche's (RHHBY.PK) Lucentis for treating diabetic macular edema, a major cause of vision loss among those with diabetes. Lucentis is already approved for two other uses. The FDA also approves a fully automated vitamin D test that will increase Roche's roster of bone metabolism tests.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)